Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
Tobe SW, Clase CM, Gao P, McQueen M, Grosshennig A, Wang X, Teo KK, Yusuf S, Mann JF; ONTARGET and TRANSCEND Investigators. Tobe SW, et al. Among authors: grosshennig a. Circulation. 2011 Mar 15;123(10):1098-107. doi: 10.1161/CIRCULATIONAHA.110.964171. Epub 2011 Feb 28. Circulation. 2011. PMID: 21357827 Clinical Trial.
Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.
Clase CM, Gao P, Tobe SW, McQueen MJ, Grosshennig A, Teo KK, Yusuf S, Mann JF; ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease). Clase CM, et al. Among authors: grosshennig a. Ann Intern Med. 2011 Mar 1;154(5):310-8. doi: 10.7326/0003-4819-154-5-201103010-00005. Ann Intern Med. 2011. PMID: 21357908
The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial.
Müller-Vahl KR, Pisarenko A, Ringlstetter R, Cimpianu CL, Fremer C, Weidinger E, Jenz EB, Musil R, Brunnauer A, Großhennig A. Müller-Vahl KR, et al. Among authors: grosshennig a. Cannabis Cannabinoid Res. 2024 Jan 23. doi: 10.1089/can.2023.0114. Online ahead of print. Cannabis Cannabinoid Res. 2024. PMID: 38265476
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial.
Bavendiek U, Großhennig A, Schwab J, Berliner D, Liu X, Maier L, Gaspar T, Rieth A, Philipp S, Hambrecht R, Westenfeld R, Münzel T, Winkler S, Hülsmann M, Westermann D, Zdravkovic M, Lichtinghagen R, von der Leyen H, Zimmermann S, Veltmann C, Böhm M, Störk S, Koch A, Bauersachs J. Bavendiek U, et al. Among authors: grosshennig a. Clin Res Cardiol. 2023 Aug;112(8):1096-1107. doi: 10.1007/s00392-023-02199-z. Epub 2023 Apr 22. Clin Res Cardiol. 2023. PMID: 37087503 Free PMC article. Clinical Trial.
Reply to Li and Colleagues.
Kratz CP, Smirnov D, Autry R, Jäger N, Waszak SM, Großhennig A, Berutti R, Wendorff M, Hainaut P, Pfister SM, Prokisch H, Ripperger T, Malkin D. Kratz CP, et al. Among authors: grosshennig a. J Natl Cancer Inst. 2023 Jun 8;115(6):760-761. doi: 10.1093/jnci/djad057. J Natl Cancer Inst. 2023. PMID: 37004196 No abstract available.
BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial.
Stahl K, Klein F, Voigtländer T, Großhennig A, Book T, Müller T, Wree A, Kuellmer A, Weigt J, Dechene A, Wedi E, Kandulski A, Lange CM, Holzwart D, von Witzendorff D, Ringe KI, Wedemeyer H, Heidrich B; BISCIT Study group. Stahl K, et al. Among authors: grosshennig a. Trials. 2023 Mar 31;24(1):247. doi: 10.1186/s13063-023-07260-w. Trials. 2023. PMID: 37004078 Free PMC article.
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.
Müller-Vahl KR, Pisarenko A, Szejko N, Haas M, Fremer C, Jakubovski E, Musil R, Münchau A, Neuner I, Huys D, van Elst LT, Schröder C, Ringlstetter R, Koch A, Jenz EB, Großhennig A. Müller-Vahl KR, et al. Among authors: grosshennig a. Psychiatry Res. 2023 May;323:115135. doi: 10.1016/j.psychres.2023.115135. Epub 2023 Feb 28. Psychiatry Res. 2023. PMID: 36878177 Free article. Clinical Trial.
81 results